BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 30807796)

  • 1. A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
    Gkanatsiou E; Portelius E; Toomey CE; Blennow K; Zetterberg H; Lashley T; Brinkmalm G
    Neurosci Lett; 2019 May; 701():125-131. PubMed ID: 30807796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-β plaques may be reduced in advanced stages of cerebral amyloid angiopathy in the elderly.
    Okamoto K; Amari M; Fukuda T; Suzuki K; Takatama M
    Neuropathology; 2020 Oct; 40(5):474-481. PubMed ID: 32557936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical traits of cerebral amyloid angiopathy in familial British-, Danish-, and non-Alzheimer's dementias.
    Michno W; Koutarapu S; Camacho R; Toomey C; Stringer K; Minta K; Ge J; Jha D; Fernandez-Rodriguez J; Brinkmalm G; Zetterberg H; Blennow K; Ryan NS; Lashley T; Hanrieder J
    J Neurochem; 2022 Nov; 163(3):233-246. PubMed ID: 36102248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
    Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
    Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
    Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
    Attems J; Jellinger KA; Lintner F
    Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
    Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
    Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-truncated Aβ2-X starting with position two in sporadic Alzheimer's disease cases and two Alzheimer mouse models.
    Savastano A; Klafki H; Haußmann U; Oberstein TJ; Muller P; Wirths O; Wiltfang J; Bayer TA
    J Alzheimers Dis; 2016; 49(1):101-10. PubMed ID: 26529393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of cerebral amyloid angiopathy define histopathological phenotypes in Alzheimer's disease.
    Allen N; Robinson AC; Snowden J; Davidson YS; Mann DM
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):136-48. PubMed ID: 23808763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The coarse-grained plaque: a divergent Aβ plaque-type in early-onset Alzheimer's disease.
    Boon BDC; Bulk M; Jonker AJ; Morrema THJ; van den Berg E; Popovic M; Walter J; Kumar S; van der Lee SJ; Holstege H; Zhu X; Van Nostrand WE; Natté R; van der Weerd L; Bouwman FH; van de Berg WDJ; Rozemuller AJM; Hoozemans JJM
    Acta Neuropathol; 2020 Dec; 140(6):811-830. PubMed ID: 32926214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-onset formation of parenchymal plaque amyloid abrogates cerebral microvascular amyloid accumulation in transgenic mice.
    Xu F; Kotarba AE; Ou-Yang MH; Fu Z; Davis J; Smith SO; Van Nostrand WE
    J Biol Chem; 2014 Jun; 289(25):17895-908. PubMed ID: 24828504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Origins of Beta Amyloid Differ Between Vascular Amyloid Deposition and Parenchymal Amyloid Plaques in the Spinal Cord of a Mouse Model of Alzheimer's Disease.
    Yuan Q; Liu X; Xian YF; Tang Y; Zou J; Zhang X; Huang P; Wu W; Song YQ; Lin ZX
    Mol Neurobiol; 2020 Jan; 57(1):278-289. PubMed ID: 31325023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation.
    Cho HS; Hyman BT; Greenberg SM; Rebeck GW
    J Neuropathol Exp Neurol; 2001 Apr; 60(4):342-9. PubMed ID: 11305869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction.
    Chung YC; Kruyer A; Yao Y; Feierman E; Richards A; Strickland S; Norris EH
    J Thromb Haemost; 2016 Jul; 14(7):1442-52. PubMed ID: 27090576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
    Attems J; Lintner F; Jellinger KA
    Acta Neuropathol; 2004 Apr; 107(4):283-91. PubMed ID: 14986026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A shift in microglial β-amyloid binding in Alzheimer's disease is associated with cerebral amyloid angiopathy.
    Zabel M; Schrag M; Crofton A; Tung S; Beaufond P; Van Ornam J; Dininni A; Vinters HV; Coppola G; Kirsch WM
    Brain Pathol; 2013 Jul; 23(4):390-401. PubMed ID: 23134465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer's disease brains: Implications for in-vivo diagnostics.
    den Haan J; Morrema THJ; Rozemuller AJ; Bouwman FH; Hoozemans JJM
    Acta Neuropathol Commun; 2018 Aug; 6(1):75. PubMed ID: 30092839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (Aβ) and colocalizes with deposited Aβ in cerebral amyloid angiopathy.
    de Jager M; Boot MV; Bol JG; Brevé JJ; Jongenelen CA; Drukarch B; Wilhelmus MM
    Neuropathol Appl Neurobiol; 2016 Apr; 42(3):255-72. PubMed ID: 25871449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways.
    Greenberg SM; Bacskai BJ; Hernandez-Guillamon M; Pruzin J; Sperling R; van Veluw SJ
    Nat Rev Neurol; 2020 Jan; 16(1):30-42. PubMed ID: 31827267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.